Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells

Teresa Troiani(University of Campania "Luigi Vanvitelli"), Fortunato Ciardiello(University of Naples Federico II)
British Journal of Cancer
May 1, 2012
10.1038/bjc.2012.129
Cited by 47

Related Papers

Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer
|Journal of Clinical Oncology|2015|795
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors
|British Journal of Cancer|2011|52
Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
|PLoS ONE|2011|43